載入中
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
最新資料
US$73.89
+US$1.91 · +2.65%
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
前收盤價
US$73.89
+US$1.91 · +2.65%
盤中時間採用ET。市場資料可能有所延遲。
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
日內區間
目前US$73.89
52週區間
目前US$73.89
盤中時間採用ET。市場資料可能有所延遲。
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
日內區間
目前US$73.89
52週區間
目前US$73.89
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 8.83億 USD | 6.14億 USD | 4.87億 USD | 3.16億 USD | 2.16億 USD |
| 銷貨成本 | 4.33億 USD | 2.5億 USD | 1.82億 USD | 1.39億 USD | 1.01億 USD |
| 毛利 | 4.51億 USD | 3.64億 USD | 3.05億 USD | 1.78億 USD | 1.16億 USD |
| 研究與開發 | 5166.4萬 USD | 4458.1萬 USD | 3428.6萬 USD | 2231.8萬 USD | 1136.9萬 USD |
| 銷售、一般及管理費用 | 3.18億 USD | 2.5億 USD | 1.62億 USD | 1.24億 USD | 8429.4萬 USD |
| 營業費用 | 3.69億 USD | 3.64億 USD | 2.58億 USD | 2.13億 USD | 1.55億 USD |
| 利息支出 | 2006萬 USD | 1760.2萬 USD | 2694萬 USD | 2805.2萬 USD | 1192.2萬 USD |
| 折舊和攤銷 | 9141.7萬 USD | 6773.1萬 USD | 5979.1萬 USD | 5965.3萬 USD | 4725.2萬 USD |
| 營業利益 | 8123萬 USD | 58.4萬 USD | 4697.1萬 USD | −3528.3萬 USD | −3979.3萬 USD |
| 淨利 | 7833.7萬 USD | −1852.2萬 USD | 1877.9萬 USD | −4789.6萬 USD | −4260.3萬 USD |
公司資料更新於 2026年10月11日。
報告持有此股票曝險的交易所交易基金。
iShares Core S&P Small-Cap ETFIJR8656.48萬0.08%1031.91億 USD0.06%US$137.55+0.17%
Avantis U.S. Small Cap Value ETFAVUV5403.17萬0.17%308.51億 USD0.25%US$119.64-0.41%
Vanguard Morningstar Total Stock Market ETFVTI4502.11萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM3877.65萬0.05%787.4億 USD0.19%US$278.94+0.49%
Invesco Pharmaceuticals ETFPJP1723.19萬3.14%5.48億 USD0.58%US$122.88+1.56%
Vanguard Extended Market ETFVXF1547.39萬0.02%954億 USD0.05%US$235+0.80%
iShares Russell 2000 Growth ETFIWO1359.64萬0.10%139.17億 USD0.24%US$356.78+0.94%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM1331.54萬0.08%158.4億 USD0.03%US$53.45+0.17%iShares Core S&P Small-Cap ETFIJRAvantis U.S. Small Cap Value ETFAVUVVanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMInvesco Pharmaceuticals ETFPJPVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
